0001854359-21-000001.txt : 20210331 0001854359-21-000001.hdr.sgml : 20210331 20210331142911 ACCESSION NUMBER: 0001854359-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210331 DATE AS OF CHANGE: 20210331 EFFECTIVENESS DATE: 20210331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZWI Therapeutics, Inc. CENTRAL INDEX KEY: 0001854359 IRS NUMBER: 844047568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-394203 FILM NUMBER: 21792501 BUSINESS ADDRESS: STREET 1: 210 BROADWAY, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 781-801-6172 MAIL ADDRESS: STREET 1: 210 BROADWAY, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001854359 ZWI Therapeutics, Inc. 210 BROADWAY, SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 781-801-6172 DELAWARE None None Corporation true 2019 ANDREW KEEFE 210 BROADWAY, SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer Director SHAOYI JIANG 210 BROADWAY, SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 Director ROBERT LANGER 210 BROADWAY, SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 Director XIN HUANG 210 BROADWAY, SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 Director CHENG XING 210 BROADWAY, SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2021-03-17 false true false 0 10000000 5000000 5000000 The Total Remaining to be Sold will be issued and sold upon the achievement by the Company of certain contingencies at a milestone closing. true 0 2 0 0 0 false ZWI Therapeutics, Inc. /s/ Andrew Keefe Andrew Keefe Chief Executive Officer 2021-03-31